Literature DB >> 26177701

Retrospective Analysis of Clinicopathological Characteristics of Pregnancy Associated Melanoma.

Melinda Fábián1, Veronika Tóth, Beáta Somlai, Judit Hársing, Enikő Kuroli, Fanni Rencz, Daniella Kuzmanovszki, József Szakonyi, Béla Tóth, Sarolta Kárpáti.   

Abstract

Pregnancy associated melanoma (PAM) by definition appears during pregnancy or within 1 year after delivery. In this retrospective study we analysed the pathological characteristics and survival rate of PAM and matched the data with non-pregnant age- and stage-matched control patients. Between 2003 and 2014, 34 pregnant women (aged 32.5 ± 5.6 years) were diagnosed with melanoma at the Department of Dermatology, Venereology and Dermatooncology of the Semmelweis University. During the pathological process histologic subtype, Breslow thickness and Clark level, tumor cell type, mitotic rate, peritumoral inflammation, as well as ulceration, regression, necrosis, vascular invasion and presence of satellite were analyzed and related to clinical data. Primary tumor location and clinical staging, disease course, local recurrence and metastases, 5-year survival rate, other tumor development before or after the diagnosis of melanoma have also been documented. We found no difference in all parameters between pregnant and non-pregnant melanoma cases except peritumoral inflammation which was higher in PAM group, moreover the presence of mild inflammation was significantly higher in PAM group compared to non-pregnancy associated melanoma (NPAM) women group.

Entities:  

Mesh:

Year:  2015        PMID: 26177701     DOI: 10.1007/s12253-015-9961-4

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  28 in total

1.  Gender-related differences in outcome for melanoma patients.

Authors:  Charles R Scoggins; Merrick I Ross; Douglas S Reintgen; R Dirk Noyes; James S Goydos; Peter D Beitsch; Marshall M Urist; Stephan Ariyan; Jeffrey J Sussman; Michael J Edwards; Anees B Chagpar; Robert C G Martin; Arnold J Stromberg; Lee Hagendoorn; Kelly M McMasters
Journal:  Ann Surg       Date:  2006-05       Impact factor: 12.969

2.  Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  G Pentheroudakis; R Orecchia; H J Hoekstra; N Pavlidis
Journal:  Ann Oncol       Date:  2010-05       Impact factor: 32.976

3.  Tumor-infiltrating lymphocytes predict cutaneous melanoma survival.

Authors:  Cristina Fortes; Simona Mastroeni; Thomas J Mannooranparampil; Francesca Passarelli; Alba Zappalà; Giorgio Annessi; Claudia Marino; Alessio Caggiati; Nicoletta Russo; Paola Michelozzi
Journal:  Melanoma Res       Date:  2015-08       Impact factor: 3.599

4.  Protocol for the examination of specimens from patients with melanoma of the skin.

Authors:  David P Frishberg; Charles Balch; Bonnie L Balzer; A Neil Crowson; Mikund Didolkar; Jennifer M McNiff; Roger R Perry; Victor G Prieto; Priya Rao; M Timothy Smith; Bruce Robert Smoller; Mark R Wick
Journal:  Arch Pathol Lab Med       Date:  2009-10       Impact factor: 5.534

5.  Melanoma of the Vulva with Pregnancy.

Authors:  S G Clayton
Journal:  Proc R Soc Med       Date:  1946-07

6.  Cancer during pregnancy and the postpartum period: A population-based study.

Authors:  Therese M-L Andersson; Anna L V Johansson; Irma Fredriksson; Mats Lambe
Journal:  Cancer       Date:  2015-03-03       Impact factor: 6.860

Review 7.  Increased mortality for pregnancy-associated melanoma: systematic review and meta-analysis.

Authors:  L Byrom; C Olsen; L Knight; K Khosrotehrani; A C Green
Journal:  J Eur Acad Dermatol Venereol       Date:  2015-02-17       Impact factor: 6.166

8.  Effect of pregnancy on survival in women with cutaneous malignant melanoma.

Authors:  Marko B Lens; Inger Rosdahl; Anders Ahlbom; Bahman Y Farahmand; Ingrid Synnerstad; Bernt Boeryd; Julia A Newton Bishop
Journal:  J Clin Oncol       Date:  2004-11-01       Impact factor: 44.544

9.  T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma.

Authors:  Andrea Ladányi; Beáta Somlai; Katalin Gilde; Zsuzsanna Fejös; István Gaudi; József Tímár
Journal:  Clin Cancer Res       Date:  2004-01-15       Impact factor: 12.531

10.  Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study.

Authors:  Hanne Stensheim; Bjørn Møller; Tini van Dijk; Sophie D Fosså
Journal:  J Clin Oncol       Date:  2008-11-24       Impact factor: 44.544

View more
  2 in total

1.  Melanoma in women of childbearing age and in pregnancy in California, 1994-2015: a population-based cohort study.

Authors:  M Kiuru; Q Li; G Zhu; J R Terrell; K Beroukhim; E Maverakis; T H M Keegan
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-08-23       Impact factor: 9.228

2.  Conjunctival Melanoma during Pregnancy.

Authors:  Rana'a T Al-Jamal; Hardeep Singh Mudhar; Zanna Currie; Ian G Rennie; Sachin M Salvi
Journal:  Ocul Oncol Pathol       Date:  2016-11-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.